Pleasanton, CA 6/29/17—Biological tools firm Unchained Labs has purchased Trinean for an undisclosed amount. Trinean provides the DropSense systems for measuring protein, DNA and RNA concentrations. “Concentration measurement is central to everything our customers do, and DropSense96 is the only product in the world that does it for biologics at high concentration with high throughput,” commented Unchained Labs Founder and CEO Tim Harkness. Unchained Labs raised $13 million in Series C funding in connection with the deal. Unchained Labs generates annual revenues of more than $35 million with eight product lines.

Trinean has 23 employees, which will expand Unchained Lab’s total staff to over 130 people, according to an Unchained Labs spokesperson. Asked about how Trinean’s systems fits with Unchained Labs’ other product lines, he told IBO, “Every researcher working on biologics needs to know how much protein is in their sample, before and after sample prep, purification, characterization and every other step of the development process.” He added, “We will also continue to sell the DropSense96 and DropSense16 to genomics customers measuring DNA and RNA concentrations.” Since its establishment in 2015, Unchained Labs has acquired Optim technology (see IBO 2/28/15), AVIA Biosystems, Avid Nano (see IBO 10/31/15) and Freeslate (see IBO 2/29/16).